WuXi AppTec Co., Ltd.
198 HKD
+2.27% day
A Chinese contract research and manufacturing company, listed in Shanghai and Hong Kong, that makes drug ingredients and runs lab work for Western pharmaceutical firms. Its share price tracks how far Washington lets that dependence run.
Nov 9 · 198.0 HKD · −4.8% vs the window’s open
the numbers21
| when | value | change |
|---|---|---|
| Oct 9high | 208.0 HKD | |
| Oct 12 | 207.8 HKD | −0.1% |
| Oct 13 | 207.4 HKD | −0.2% |
| Oct 14 | 202.0 HKD | −2.6% |
| Oct 15 | 200.6 HKD | −0.7% |
| Oct 16 | 196.2 HKD | −2.2% |
| Oct 20 | 196.5 HKD | +0.2% |
| Oct 21 | 196.0 HKD | −0.3% |
| Oct 22 | 184.2 HKD | −6.0% |
| Oct 23 | 186.0 HKD | +1.0% |
| Oct 26 | 188.3 HKD | +1.2% |
| Oct 27 | 185.6 HKD | −1.4% |
| Oct 28 | 190.6 HKD | +2.7% |
| Oct 29 | 191.1 HKD | +0.3% |
| Oct 30 | 185.4 HKD | −3.0% |
| Nov 2 | 180.0 HKD | −2.9% |
| Nov 3low | 176.0 HKD | −2.2% |
| Nov 4 | 197.8 HKD | +12.4% |
| Nov 5 | 204.4 HKD | +3.3% |
| Nov 6 | 193.6 HKD | −5.3% |
| Nov 9latest | 198.0 HKD | +2.3% |
Lately
The Pentagon dropped WuXi AppTec from its 'Chinese military companies' list to comply with a court ruling. That entry would have opened the way to naming it a biotech 'company of concern' under the BIOSECURE push, the step that decides whether US drugmakers can keep it as a supplier.